The Contribution of Heels for Walking Quality Among Children With Muscular Dystrophy
Completed
- Conditions
- Step Time and Length VariabilityStep Time and LengthSymmetryGait VelocityHeart Rate
- Registration Number
- NCT01638169
- Lead Sponsor
- Alyn Pediatric & Adolescent Rehabilitation Hospital
- Brief Summary
During the stand phase the DMD foot is too plantarflexed in addition patients adopt a higher flexion and abduction of the hip in order to advance the swinging limb. The aim of this work is to assess the immediate contribution of heels for these walking disturbance in children with muscular dystrophy disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 11
Inclusion Criteria
- age >6 yrs
- walk without heel strike
Exclusion Criteria
- cannot understand simple instructions
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method gait parameters pre and post heels adj.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie gait abnormalities in DMD patients with plantarflexed feet?
How does adding a heel compare to orthotic interventions in improving gait symmetry in muscular dystrophy?
Are there specific biomarkers that correlate with step time and length variability in DMD patients using heel devices?
What adverse events are associated with heel use in pediatric muscular dystrophy populations and how are they managed?
What combination therapies or devices are being explored alongside heel interventions for DMD gait correction?
Trial Locations
- Locations (1)
Alyn
🇮🇱Jerusalem, Israel
Alyn🇮🇱Jerusalem, Israel